BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33995640)

  • 1. Neuropilin-1 predicts poor prognosis and promotes tumor metastasis through epithelial-mesenchymal transition in gastric cancer.
    Jin Q; Ren Q; Chang X; Yu H; Jin X; Lu X; He N; Wang G
    J Cancer; 2021; 12(12):3648-3659. PubMed ID: 33995640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropilin-1 Interacts with Fibronectin-1 to Promote Epithelial-Mesenchymal Transition Progress in Gastric Cancer.
    Wu C; Zeng MH; Liao G; Qian K; Li H
    Onco Targets Ther; 2020; 13():10677-10687. PubMed ID: 33116644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
    Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
    Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MST4 Predicts Poor Prognosis And Promotes Metastasis By Facilitating Epithelial-Mesenchymal Transition In Gastric Cancer.
    Li T; Deng L; He X; Jiang G; Hu F; Ye S; You Y; Duanmu J; Dai H; Huang G; Tang C; Lei X
    Cancer Manag Res; 2019; 11():9353-9369. PubMed ID: 31807065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-19b-3p suppresses gastric cancer development by negatively regulating neuropilin-1.
    Wei Y; Guo S; Tang J; Wen J; Wang H; Hu X; Gu Q
    Cancer Cell Int; 2020; 20():193. PubMed ID: 32508529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
    Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
    Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
    J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
    Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
    PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor-like domain multiple 6 (EGFL6) promotes the migration and invasion of gastric cancer cells by inducing epithelial-mesenchymal transition.
    Huo FC; Zhu WT; Liu X; Zhou Y; Zhang LS; Mou J
    Invest New Drugs; 2021 Apr; 39(2):304-316. PubMed ID: 32949323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulatory mechanism and biological significance of the Snail-miR590-VEGFR-NRP1 axis in the angiogenesis, growth and metastasis of gastric cancer.
    Mei B; Chen J; Yang N; Peng Y
    Cell Death Dis; 2020 Apr; 11(4):241. PubMed ID: 32303680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC01268 promotes epithelial-mesenchymal transition, invasion and metastasis of gastric cancer
    Tang LH; Ye PC; Yao L; Luo YJ; Tan W; Xiang WP; Liu ZL; Tan L; Xiao JW
    World J Gastrointest Oncol; 2023 Aug; 15(8):1366-1383. PubMed ID: 37663944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACK1 promotes gastric cancer epithelial-mesenchymal transition and metastasis through AKT-POU2F1-ECD signalling.
    Xu SH; Huang JZ; Xu ML; Yu G; Yin XF; Chen D; Yan GR
    J Pathol; 2015 Jun; 236(2):175-85. PubMed ID: 25678401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM14 promotes the migration and invasion of gastric cancer by regulating epithelial‑to‑mesenchymal transition via activation of AKT signaling regulated by miR‑195‑5p.
    Wang F; Ruan L; Yang J; Zhao Q; Wei W
    Oncol Rep; 2018 Dec; 40(6):3273-3284. PubMed ID: 30272351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
    Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
    Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer.
    Chong Y; Tang D; Xiong Q; Jiang X; Xu C; Huang Y; Wang J; Zhou H; Shi Y; Wu X; Wang D
    J Exp Clin Cancer Res; 2016 Nov; 35(1):175. PubMed ID: 27836001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
    Xu M; Qin S; Cao F; Ding S; Li M
    Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-21 Promotes the Invasion and Metastasis of Gastric Cancer Cells by Activating Epithelial-Mesenchymal Transition.
    Xiao T; Jie Z
    Eur Surg Res; 2019; 60(5-6):208-218. PubMed ID: 31722341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
    Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y
    Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NETO2 promotes invasion and metastasis of gastric cancer cells via activation of PI3K/Akt/NF-κB/Snail axis and predicts outcome of the patients.
    Liu JY; Jiang L; He T; Liu JJ; Fan JY; Xu XH; Tang B; Shi Y; Zhao YL; Qian F; Wang Y; Cui YH; Yu PW
    Cell Death Dis; 2019 Feb; 10(3):162. PubMed ID: 30770791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.